Gift Ahimbisibwe, Marjorie Nakibuule, Marvin Martin Ssejoba, David Oyamo, Rose Mulwana, Josephine Nabulime, Febronius Babirye, Musana Abdusalaamu Kizito,
Hervé Lekuya Monka, Akello Suzan Adakun, et al.
Introduction: If we are to break new ground in difficult-to-treat or difficult-to-vaccinate diseases (such as HIV, malaria, or tuberculosis), we must have a better understanding of the immune system at the site of infection in humans. For tuberculosis (TB), the initial site of infection is the lungs, but obtaining lung tissues from subjects suffering from TB has been limited to bronchoalveolar lavage (BAL) or sputum sampling, or surgical ...